Crossmark

Early stage non-small cell lung cancer treated with pencil beam scanning particle therapy: retrospective analysis of early results on safety and efficacy

Crossref DOI link: https://doi.org/10.1186/s13014-019-1216-1

Published Online: 2019-01-25

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Jian

Lu, Jiade J.

Ma, Ningyi

Zhao, Jingfang

Chen, Chang

Fan, Min

Jiang, Guoliang

Mao, Jingfang
Funding

Funding for this research was provided by:

Shanghai Shen Kang Hospital Development Center New Frontier Technology Joint Project of municipal hospital (SHDC12017114, SHDC12017114, SHDC12017114, SHDC12017114)

Shanghai Science and Technology Development Funds (15411950103, 15411950103, 18ZR1436300, 14411965800)

Shanghai Pudong New Area Science and Technology Development Fund for the People's Livelihood Research Project (PKJ2017-Y52)
License Information

Text and Data Mining valid from 2019-01-25
More Information

Article History

Received: 5 September 2018

Accepted: 8 January 2019

First Online: 25 January 2019

Ethics approval and consent to participate

: This retrospective study was approved by the institutional review board and written informed consents from all patients were obtained.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below